Research has employed IgM antibodies produced from B-2 cells to evaluate the pathologic assessment of antibody-mediated rejection (AMR) in transplant recipients. However, there may be some difficulties in producing monoclonal IgM antibodies from B-2 cells.
For more: https://non-igg-ab.creativ...